CDA and neoplasm: As a pro-drug, GEM has to enter the tumor cell to become active, and a major part of GEM is converted into the inactive metabolite 2′,2′-difluorodeoxyuridine (dFdU) by the deamination effect of cytidine deaminase (CDA).